49.29 USD
+0.74 (+1.52%)
49.29 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 81% to SKWD. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 62.63. This target is 27.06% above the current price.
SKWD was analyzed by 18 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about SKWD.
In the previous month the buy percentage consensus was at a similar level.
SKWD was analyzed by 18 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-31 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-10-30 | Citizens | Maintains | Market Outperform -> Market Outperform |
| 2025-10-06 | Janney Montgomery Scott | Initiate | Buy |
| 2025-09-08 | BMO Capital | Maintains | Market Perform -> Market Perform |
| 2025-09-04 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2025-08-01 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-05-29 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2025-05-08 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2025-05-05 | Truist Securities | Maintains | Buy -> Buy |
| 2025-05-05 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-05-02 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2025-04-11 | Barclays | Maintains | Overweight -> Overweight |
| 2025-04-11 | Jefferies | Downgrade | Buy -> Hold |
| 2025-04-09 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2025-03-14 | Barclays | Upgrade | Equal-Weight -> Overweight |
| 2025-03-03 | Citizens Capital Markets | Reiterate | Market Outperform -> Market Outperform |
| 2025-02-28 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2025-02-28 | Wolfe Research | Downgrade | Outperform -> Peer Perform |
| 2025-02-27 | Truist Securities | Maintains | Buy -> Buy |
| 2025-02-10 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-02-06 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2025-02-06 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-01-13 | TD Cowen | Initiate | Hold |
| 2025-01-06 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2024-11-05 | Raymond James | Maintains | Strong Buy -> Strong Buy |
| 2024-10-30 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-10-30 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2024-10-15 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-10-09 | Jefferies | Maintains | Buy -> Buy |
| 2024-09-04 | Barclays | Initiate | Equal-Weight |
SKYWARD SPECIALTY INSURANCE / SKWD FAQ
What is the price target for SKWD stock?
18 analysts have analysed SKWD and the average price target is 62.63 USD. This implies a price increase of 27.06% is expected in the next year compared to the current price of 49.29.
Can you provide the consensus rating for SKYWARD SPECIALTY INSURANCE stock?
The consensus rating for SKYWARD SPECIALTY INSURANCE (SKWD) is 81.1111 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts have analysed SKYWARD SPECIALTY INSURANCE (SKWD)?
The number of analysts covering SKYWARD SPECIALTY INSURANCE (SKWD) is 18.